Company Analysis

Fortrea Holdings Inc. (FTRE)

Nasdaq: FTRE · Services-Medical Laboratories · Durham, NC · filing with the SEC since 2023
Grade3.3
◀ Past 3.5● Present 2.9▶ Future 3.5
1 est.

Filings

127 filings since 2017 beside 211 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 29 days after the quarter ended. The proxy statement was last filed Apr 27, 2026.

Filings a yearinsider forms included
787011476
2023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 17 times in the last 36 months, the newest Sep 30, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2024.
Insider forms 211

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 29, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 29, 2026 10-Q Quarterly report Sep 30, 2026
Sep 30, 2026 8-K item 5.02 Officer or director change · Current report Sep 29, 2026
Sep 10, 2026 8-K item 5.02 Officer or director change · Current report Sep 9, 2026
Jul 29, 2026 10-Q Quarterly report Jun 30, 2026
Jul 29, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report Jul 27, 2026
Jul 14, 2026 8-K item 5.02 Officer or director change · Current report Jul 8, 2026
Jun 26, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Jun 12, 2026 8-K item 5.07 Shareholder vote · Current report Jun 9, 2026
May 5, 2026 10-Q Quarterly report Mar 31, 2026
May 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 27, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 27, 2026 DEFA14A Extra proxy material
Apr 27, 2026 DEF 14A Proxy statement Jun 9, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 26, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 20, 2025 8-K item 7.01 Investor disclosure (Regulation FD) · Current report Nov 18, 2025
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Nov 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Sep 22, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Sep 19, 2025
Aug 29, 2025 S-8 Employee stock plan registration
Aug 29, 2025 S-8 Employee stock plan registration
Aug 27, 2025 8-K item 5.02 Officer or director change · Current report Aug 21, 2025
Aug 14, 2025 SCHEDULE 13G Large holder notice
Aug 13, 2025 SCHEDULE 13G Large holder notice
Aug 6, 2025 10-Q Quarterly report Jun 30, 2025
Aug 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 5, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 29, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 17, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 15, 2025 SCHEDULE 13G/A Large holder update, amended
Jun 12, 2025 8-K items 5.02, 5.07 Officer or director change; Shareholder vote · Current report Jun 10, 2025
Jun 12, 2025 8-A12B Class of securities registered for listing
Jun 12, 2025 8-K items 1.01, 3.03, 5.03, 8.01, 9.01 Major agreement signed; Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report Jun 11, 2025
Jun 11, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
40 of 127 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton FTRE · research, not advice